Insider · CIK 0001378588

Deshpande Milind

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001378588

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-23	SPROSpero Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	101,454
2026-06-23	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2025-06-12	SPROSpero Therapeutics, Inc.A Award	Director	AAward	+20K sh	—	—	91,454
2024-05-29	SPROSpero Therapeutics, Inc.A Award	Director	AAward	+20K sh	—	—	71,454
2023-10-05	SPROSpero Therapeutics, Inc.A Award	Director	AAward	+20K sh	—	—	51,454
2022-09-15	SPROSpero Therapeutics, Inc.A Award	Director	AAward	+15K sh	—	—	31,454
2021-08-17	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2021-01-04	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,629 sh	$13.31	+$35K	2,629
2020-10-27	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-01-02	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,408 sh	$6.47	+$35K	5,408
2019-06-05	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,073 sh	—	—	6,073
2018-06-05	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,073 sh	—	—	6,073
2018-02-09	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	Director, Chief Executive Officer	AAward	+640K sh	—	—	640,000
2017-01-17	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	Director, Chief Executive Officer	AAward	+458K sh	—	—	458,000
2016-12-02	ACHILLION PHARMACEUTICALS INCP Purchase	Director, Chief Executive Officer	PPurchase	+2,500 sh	$4.06	+$10.1K	2,500
2016-01-20	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	Director, Chief Executive Officer	AAward	+400K sh	—	—	400,000
2015-01-21	ACHILLION PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−100K sh	$15.00	−$1.5M	0
2015-01-21	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−100K sh	—	—	300,000
2015-01-21	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+100K sh	$3.02	+$302K	100,000
2014-12-02	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+345K sh	—	—	345,000
2014-08-18	ACHILLION PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−60K sh	$10.00	−$600K	0
2014-08-18	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+16.3K sh	$4.00	+$65K	16,250
2014-08-18	ACHILLION PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−16.3K sh	$10.00	−$163K	0
2014-08-18	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+16K sh	$1.05	+$16.7K	15,950
2014-08-18	ACHILLION PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−16K sh	$10.00	−$160K	0
2014-08-18	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+60K sh	$3.28	+$197K	60,000
2014-08-18	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+124K sh	$3.10	+$386K	124,424
2014-08-18	ACHILLION PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−124K sh	$10.00	−$1.24M	0
2014-08-18	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−16.3K sh	—	—	0
2014-08-18	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−16K sh	—	—	0
2014-08-18	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−60K sh	—	—	0
2014-08-18	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−124K sh	—	—	75,576
2013-12-17	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+400K sh	—	—	400,000
2013-05-28	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+600K sh	—	—	600,000
2012-12-18	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+145K sh	—	—	145,000
2012-03-15	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,312 sh	$1.05	+$5,577.6	5,312
2012-03-15	ACHILLION PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−5,312 sh	$10.70	−$56.8K	0
2012-03-15	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−5,312 sh	—	—	15,950
2012-01-09	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+10.6K sh	$1.05	+$11.2K	10,625
2012-01-09	ACHILLION PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−10.6K sh	$9.34	−$99.2K	0
2012-01-09	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−10.6K sh	—	—	21,262
2011-12-12	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2011-06-28	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+18.8K sh	—	—	0
2011-06-28	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.1K sh	—	—	0
2011-06-28	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,313 sh	—	—	31,887
2011-06-28	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+12.5K sh	$1.60	+$20K	12,500
2011-06-28	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+18.8K sh	$1.60	+$30K	31,250
2011-06-28	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.1K sh	$1.60	+$21K	44,375
2011-06-28	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,313 sh	$1.05	+$5,578.65	49,688
2011-06-28	ACHILLION PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−44.4K sh	$8.05	−$357K	5,313

Recent filings

Accepted (ET)
Jun 254
Deshpande Milind0001193125-26-283245
SEC(opens sec.gov)
Jun 164
Deshpande Milind0000950170-25-087020
SEC(opens sec.gov)
May 304
Deshpande Milind0000950170-24-066659
SEC(opens sec.gov)
Oct 104
Deshpande Milind0000950170-23-052710
SEC(opens sec.gov)
Sep 194
Deshpande Milind0000899243-22-031504
SEC(opens sec.gov)
Aug 184
Deshpande Milind0000899243-21-033469
SEC(opens sec.gov)
Jan 64
Deshpande Milind0000899243-21-000690
SEC(opens sec.gov)
Oct 274
Deshpande Milind0000899243-20-029329
SEC(opens sec.gov)
Jan 64
Deshpande Milind0000899243-20-000625
SEC(opens sec.gov)
Jun 54
Deshpande Milind0000899243-19-015665
SEC(opens sec.gov)
Jun 64
Deshpande Milind0000899243-18-015326
SEC(opens sec.gov)
Feb 134
Deshpande Milind0001209191-18-009678
SEC(opens sec.gov)
Jan 194
ACHILLION PHARMACEUTICALS INC0001209191-17-004601
SEC(opens sec.gov)
Dec 54
ACHILLION PHARMACEUTICALS INC0001209191-16-153418
SEC(opens sec.gov)
Jan 224
ACHILLION PHARMACEUTICALS INC0001209191-16-093098
SEC(opens sec.gov)
Jan 234
ACHILLION PHARMACEUTICALS INC0001181431-15-001442
SEC(opens sec.gov)
Dec 44
ACHILLION PHARMACEUTICALS INC0001181431-14-037952
SEC(opens sec.gov)

Companies

Address

C/O SPERO THERAPEUTICS, INC. 675 MASSACHUSETTS AVENUE, 14TH FLOOR

CAMBRIDGE, MA, 02139